首页 > 最新文献

Revue medicale de Liege最新文献

英文 中文
[News in the diagnosis and management of pediatric asthma]. [儿童哮喘诊断和治疗的最新进展]。
Pub Date : 2025-05-01
Ammar Elkheir, Céline Kempeneers

Asthma is a chronic inflammatory disease of the respiratory tract. The etiology is multifactorial. Despite its high prevalence, asthma is often underdiagnosed or over diagnosed, based solely on medical history without diagnostic tests. This article discusses the new guidelines for paediatric asthma diagnosis, according to the age in children and adolescents, as well as the new concepts in asthma care, including some adaptations according reimbursement criteria in the Belgian context.

哮喘是一种慢性呼吸道炎症性疾病。病因是多因素的。尽管患病率很高,但仅仅基于病史而没有诊断测试,哮喘往往被诊断不足或过度诊断。本文讨论了儿科哮喘诊断的新指南,根据儿童和青少年的年龄,以及哮喘护理的新概念,包括根据比利时背景下的报销标准进行的一些调整。
{"title":"[News in the diagnosis and management of pediatric asthma].","authors":"Ammar Elkheir, Céline Kempeneers","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Asthma is a chronic inflammatory disease of the respiratory tract. The etiology is multifactorial. Despite its high prevalence, asthma is often underdiagnosed or over diagnosed, based solely on medical history without diagnostic tests. This article discusses the new guidelines for paediatric asthma diagnosis, according to the age in children and adolescents, as well as the new concepts in asthma care, including some adaptations according reimbursement criteria in the Belgian context.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"387-393"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recommendations for the treatment of type 2 diabetes]. [2型糖尿病的治疗建议]。
Pub Date : 2025-05-01
Inès Laraki, Nicolas Paquot

The management of type 2 diabetes relies on an integrated approach that goes beyond metabolic control, also targeting the prevention of cardiovascular and renal complications. Recent guidelines emphasize the importance of a personalized therapeutic strategy, tailored to the individual characteristics of patients, their comorbidities, and based on shared decision-making. SGLT2 inhibitors and GLP-1 receptor agonists have emerged as cornerstone treatments due to their effectiveness in glycaemic control and their demonstrated protective effects on the heart and kidneys. Moreover, weight management is now considered a key therapeutic lever, offering significant metabolic and cardiovascular benefits. Beyond pharmacological choices, therapeutic education, multidisciplinary support, and addressing social determinants of health play a crucial role in optimizing treatment adherence and improving patients' quality of life. A proactive and evolving management approach, adapted to disease progression and individual patient needs, is now at the heart of type 2 diabetes recommendations.

2型糖尿病的管理依赖于一种超越代谢控制的综合方法,也针对心血管和肾脏并发症的预防。最近的指南强调了个性化治疗策略的重要性,针对患者的个体特征及其合并症进行定制,并基于共同决策。由于SGLT2抑制剂和GLP-1受体激动剂在血糖控制方面的有效性以及对心脏和肾脏的保护作用,它们已成为基础治疗方法。此外,体重管理现在被认为是一个关键的治疗杠杆,提供显著的代谢和心血管益处。除了药物选择之外,治疗教育、多学科支持和解决健康的社会决定因素在优化治疗依从性和改善患者生活质量方面发挥着至关重要的作用。目前,2型糖尿病建议的核心是采用一种适应疾病进展和患者个体需求的前瞻性和不断发展的管理方法。
{"title":"[Recommendations for the treatment of type 2 diabetes].","authors":"Inès Laraki, Nicolas Paquot","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The management of type 2 diabetes relies on an integrated approach that goes beyond metabolic control, also targeting the prevention of cardiovascular and renal complications. Recent guidelines emphasize the importance of a personalized therapeutic strategy, tailored to the individual characteristics of patients, their comorbidities, and based on shared decision-making. SGLT2 inhibitors and GLP-1 receptor agonists have emerged as cornerstone treatments due to their effectiveness in glycaemic control and their demonstrated protective effects on the heart and kidneys. Moreover, weight management is now considered a key therapeutic lever, offering significant metabolic and cardiovascular benefits. Beyond pharmacological choices, therapeutic education, multidisciplinary support, and addressing social determinants of health play a crucial role in optimizing treatment adherence and improving patients' quality of life. A proactive and evolving management approach, adapted to disease progression and individual patient needs, is now at the heart of type 2 diabetes recommendations.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"416-421"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Multidisciplinary concussion management recommendations]. [多学科脑震荡管理建议]。
Pub Date : 2025-05-01
Mélanie Louras, Aurore Thibaut, Nathalie Maquet, Michiel Meys, Gaël Delrue, Aude Barjona, Jean-François Kaux, Nicolas Lejeune, Géraldine Martens

Concussions represent a major public health concern due to their high prevalence and the risk of long-term consequences. In some patients, they can lead to persistent post-concussion symptoms lasting for several months or even years, significantly impacting their quality of life. To date, no curative treatment exists for this syndrome, but early and appropriate management plays a key role in preventing long-term complications. However, concussions often remain underdiagnosed, both by healthcare professionals and the patients themselves. Various assessment tools have been developed to facilitate the identification of concussions and to guide the gradual return to daily activities, whether sports-related, educational, or professional. This article synthesizes these tools and highlights their relevance at different stages of care : acute, subacute, and chronic. Clinicians will be better informed to improve the diagnosis and management of concussions in their respective fields. Furthermore, raising awareness among the medical and sports communities, as well as the general population, about the benefits of proper concussion management remains essential in order to optimize recovery and limit long-term negative consequences.

脑震荡发病率高,有造成长期后果的风险,是一个重大的公共卫生问题。在一些患者中,它们会导致持续数月甚至数年的脑震荡后症状,严重影响他们的生活质量。到目前为止,这种综合征还没有治愈的治疗方法,但早期和适当的管理在预防长期并发症方面起着关键作用。然而,无论是医疗保健专业人员还是患者自己,脑震荡通常都没有得到充分的诊断。已经开发了各种评估工具,以促进脑震荡的识别,并指导逐渐恢复日常活动,无论是与体育有关的,教育的还是专业的。本文综合了这些工具,并强调了它们在不同护理阶段的相关性:急性、亚急性和慢性。临床医生将得到更好的信息,以提高各自领域脑震荡的诊断和管理。此外,提高医疗界和体育界以及普通民众对适当脑震荡管理的好处的认识,对于优化康复和限制长期负面后果仍然至关重要。
{"title":"[Multidisciplinary concussion management recommendations].","authors":"Mélanie Louras, Aurore Thibaut, Nathalie Maquet, Michiel Meys, Gaël Delrue, Aude Barjona, Jean-François Kaux, Nicolas Lejeune, Géraldine Martens","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Concussions represent a major public health concern due to their high prevalence and the risk of long-term consequences. In some patients, they can lead to persistent post-concussion symptoms lasting for several months or even years, significantly impacting their quality of life. To date, no curative treatment exists for this syndrome, but early and appropriate management plays a key role in preventing long-term complications. However, concussions often remain underdiagnosed, both by healthcare professionals and the patients themselves. Various assessment tools have been developed to facilitate the identification of concussions and to guide the gradual return to daily activities, whether sports-related, educational, or professional. This article synthesizes these tools and highlights their relevance at different stages of care : acute, subacute, and chronic. Clinicians will be better informed to improve the diagnosis and management of concussions in their respective fields. Furthermore, raising awareness among the medical and sports communities, as well as the general population, about the benefits of proper concussion management remains essential in order to optimize recovery and limit long-term negative consequences.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"448-455"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Guidelines for the basic management of chronic kidney disease]. 【慢性肾脏疾病基本治疗指南】。
Pub Date : 2025-05-01
Pierre Delanaye, Nicolas Paquot, François Jouret, André Scheen

This article outlines the 2024 KDIGO («Kidney Disease: Improving Global Outcomes») guidelines to slow the progression of chronic kidney disease in adults. Non-pharmacological measures include a healthy diet (Mediterranean or vegetarian), regular physical activity (150 minutes per week), smoking cessation, and weight loss. A low-salt diet (less than 5 g of salt per day) is also recommended. The latest KDIGOs advise a protein intake of 0.8 g/kg/day, with a potential reduction for some non-diabetic patients. Concerning drug-based therapies, renin-angiotensin system inhibitors remain crucial, particularly for patients with pathological albuminuria. Sodium-glucose cotransporter 2 inhibitors are becoming a key pillar of nephroprotection, even in non-diabetic patients. Mineralocorticoid receptor antagonists like finerenone and glucagon-like peptide-1 receptor agonists further enhance therapeutic options, especially in diabetic nephropathy. Finally, contrary to previous assumptions, reducing uric acid and systematically correcting acidosis are not considered as nephroprotective measures.

本文概述了2024年KDIGO(肾脏疾病:改善全球结果)指南,以减缓成人慢性肾脏疾病的进展。非药物措施包括健康饮食(地中海或素食),定期体育活动(每周150分钟),戒烟和减肥。低盐饮食(每天少于5克盐)也是推荐的。最新的kdigo建议蛋白质摄入量为0.8 g/kg/天,对于一些非糖尿病患者可能会减少。关于基于药物的治疗,肾素-血管紧张素系统抑制剂仍然至关重要,特别是对于病理性蛋白尿患者。钠-葡萄糖共转运蛋白2抑制剂正成为肾保护的关键支柱,即使是非糖尿病患者。矿物皮质激素受体拮抗剂如细烯酮和胰高血糖素样肽-1受体激动剂进一步增加了治疗选择,特别是在糖尿病肾病中。最后,与以往的假设相反,降低尿酸和系统纠正酸中毒不被认为是肾保护措施。
{"title":"[Guidelines for the basic management of chronic kidney disease].","authors":"Pierre Delanaye, Nicolas Paquot, François Jouret, André Scheen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This article outlines the 2024 KDIGO («Kidney Disease: Improving Global Outcomes») guidelines to slow the progression of chronic kidney disease in adults. Non-pharmacological measures include a healthy diet (Mediterranean or vegetarian), regular physical activity (150 minutes per week), smoking cessation, and weight loss. A low-salt diet (less than 5 g of salt per day) is also recommended. The latest KDIGOs advise a protein intake of 0.8 g/kg/day, with a potential reduction for some non-diabetic patients. Concerning drug-based therapies, renin-angiotensin system inhibitors remain crucial, particularly for patients with pathological albuminuria. Sodium-glucose cotransporter 2 inhibitors are becoming a key pillar of nephroprotection, even in non-diabetic patients. Mineralocorticoid receptor antagonists like finerenone and glucagon-like peptide-1 receptor agonists further enhance therapeutic options, especially in diabetic nephropathy. Finally, contrary to previous assumptions, reducing uric acid and systematically correcting acidosis are not considered as nephroprotective measures.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"376-380"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Update on recommendations for the diagnosis and management of ARDS]. [关于ARDS诊断和管理的最新建议]。
Pub Date : 2025-05-01
Gilles Parzibut, Quentin Maloir, Paul Massion, Bernard Lambermont

Since its first description 50 years ago, much progress has been made in the diagnosis and management of ARDS (Acute Respiratory Distress Syndrome). In this context, we regularly benefit from updates of best guidelines. Here we present a summary of the most recent guidelines based on the latest publications from the European and American intensive care societies.

自50年前首次描述ARDS以来,在ARDS(急性呼吸窘迫综合征)的诊断和管理方面取得了很大进展。在这方面,我们经常受益于最佳指南的更新。在这里,我们根据欧洲和美国重症监护协会的最新出版物,总结了最新的指导方针。
{"title":"[Update on recommendations for the diagnosis and management of ARDS].","authors":"Gilles Parzibut, Quentin Maloir, Paul Massion, Bernard Lambermont","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Since its first description 50 years ago, much progress has been made in the diagnosis and management of ARDS (Acute Respiratory Distress Syndrome). In this context, we regularly benefit from updates of best guidelines. Here we present a summary of the most recent guidelines based on the latest publications from the European and American intensive care societies.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"334-338"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Differences between medical recommendations based on Evidence-Based Medicine (EBM) and expert consensus]. [基于循证医学(EBM)的医学建议与专家共识的差异]。
Pub Date : 2025-05-01
Régis Radermecker

The article compares recommendations based on Evidence-Based Medicine (EBM) and expert consensus. EBM utilizes scientific evidence from clinical trials to formulate objective recommendations, while expert consensus relies on the experience of recognized practitioners in the field of clinical trials, often, but not always, in the absence of sufficient data. EBM follows a systematic and rigorous methodology and provides a clear-cut classification, whereas consensus approaches are more subjective and less rigorous, even if also based on the results already available. While EBM recommendations (also called guidelines) are viewed as more transparent and verifiable, consensus report can provide useful insights where data are still scarce. Both approaches are complementary and essential for improving the quality of medical care.

本文比较了循证医学和专家共识的建议。EBM利用临床试验的科学证据来制定客观建议,而专家共识依赖于临床试验领域公认的从业人员的经验,通常(但并非总是)在缺乏足够数据的情况下。循证医学遵循系统和严格的方法,并提供明确的分类,而共识方法更主观,更不严格,即使也是基于已有的结果。虽然EBM建议(也称为指南)被认为是更透明和可验证的,但共识报告可以在数据仍然稀缺的情况下提供有用的见解。这两种方法相辅相成,对提高医疗保健质量至关重要。
{"title":"[Differences between medical recommendations based on Evidence-Based Medicine (EBM) and expert consensus].","authors":"Régis Radermecker","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The article compares recommendations based on Evidence-Based Medicine (EBM) and expert consensus. EBM utilizes scientific evidence from clinical trials to formulate objective recommendations, while expert consensus relies on the experience of recognized practitioners in the field of clinical trials, often, but not always, in the absence of sufficient data. EBM follows a systematic and rigorous methodology and provides a clear-cut classification, whereas consensus approaches are more subjective and less rigorous, even if also based on the results already available. While EBM recommendations (also called guidelines) are viewed as more transparent and verifiable, consensus report can provide useful insights where data are still scarce. Both approaches are complementary and essential for improving the quality of medical care.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"268-270"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Practical guidelines for the treatment of obsessive-compulsive disorders]. [强迫症治疗实用指南]。
Pub Date : 2025-05-01
Gabrielle Scantamburlo

Obsessive-compulsive disorders (OCD) are characterized by obsessions (recurrent, inappropriate thoughts or images) and/or compulsions (repetitive behaviours or mental acts) that cause marked impairment in functioning. This article summarizes the principles and recommendations of care for OCD. A "stepped care" approach is recommended, with increasing intensity of treatment according to severity and clinical complexity. The pillars of care articulate different components, starting with building a therapeutic alliance and psychoeducation, followed by psychotherapeutic and/or pharmacological approaches and, in cases of resistance, neuromodulation. The article integrates the need for an individualized strategy centered on an integrated brain health approach.

强迫症(OCD)的特征是强迫(反复出现的、不适当的想法或图像)和/或强迫(重复的行为或精神行为),导致明显的功能损害。本文总结了强迫症治疗的原则和建议。建议采用“阶梯式护理”方法,根据病情严重程度和临床复杂性增加治疗强度。护理的支柱阐明了不同的组成部分,首先是建立治疗联盟和心理教育,然后是心理治疗和/或药理学方法,在出现耐药性的情况下,进行神经调节。这篇文章整合了以综合大脑健康方法为中心的个性化策略的必要性。
{"title":"[Practical guidelines for the treatment of obsessive-compulsive disorders].","authors":"Gabrielle Scantamburlo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Obsessive-compulsive disorders (OCD) are characterized by obsessions (recurrent, inappropriate thoughts or images) and/or compulsions (repetitive behaviours or mental acts) that cause marked impairment in functioning. This article summarizes the principles and recommendations of care for OCD. A \"stepped care\" approach is recommended, with increasing intensity of treatment according to severity and clinical complexity. The pillars of care articulate different components, starting with building a therapeutic alliance and psychoeducation, followed by psychotherapeutic and/or pharmacological approaches and, in cases of resistance, neuromodulation. The article integrates the need for an individualized strategy centered on an integrated brain health approach.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"463-471"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recommendations for the management of kidney cancer in 2025]. [2025年肾癌治疗建议]。
Pub Date : 2025-05-01
Manon Wick, Chloé Denis, Pierre Frères, Brieuc Sautois, David Waltregny, Christine Gennigens

The incidence of kidney cancer is rising. It is the 7th most common cancer in men and the 10th most common in women. Diagnosis is based on imaging (thoraco-abdominopelvic computed tomography scan +/- abdominal magnetic resonance) and histopathology. Clear cell carcinoma is the most frequently observed histological subtype. Management of localized kidney cancer involves surgery or ablative treatments. Active surveillance is indicated in the indolent oligometastatic setting with local treatment in case of localized progression. Apart from this specific situation, two first-line therapeutic strategies are recommended in the metastatic setting : a dual immunotherapy regimen or the combination of immunotherapy with an antiangiogenic tyrosine kinase inhibitor. Both combinations have demonstrated superior survival outcomes compared to sunitinib, the previous standard of care until 2019. Treatment selection should be individualized, considering the characteristics of the disease (histology, tumour burden, location of metastases and if they are threatening, speed of progression), potential side effects of the treatments, the patient's general health, comorbidities and preferences.

肾癌的发病率正在上升。它是男性第七大常见癌症,女性第十大常见癌症。诊断是基于影像学(胸腹骨盆计算机断层扫描+/-腹部磁共振)和组织病理学。透明细胞癌是最常见的组织学亚型。局部肾癌的治疗包括手术或消融治疗。主动监测是指在惰性少转移设置与局部治疗的情况下,局部进展。除了这种特殊情况外,在转移性肿瘤中推荐两种一线治疗策略:双重免疫治疗方案或免疫治疗与抗血管生成酪氨酸激酶抑制剂的联合治疗。与舒尼替尼相比,这两种组合都显示出更好的生存结果,舒尼替尼是之前的护理标准,直到2019年。治疗选择应个体化,考虑到疾病的特点(组织学、肿瘤负担、转移的位置以及是否有威胁、进展速度)、治疗的潜在副作用、患者的一般健康状况、合并症和偏好。
{"title":"[Recommendations for the management of kidney cancer in 2025].","authors":"Manon Wick, Chloé Denis, Pierre Frères, Brieuc Sautois, David Waltregny, Christine Gennigens","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The incidence of kidney cancer is rising. It is the 7th most common cancer in men and the 10th most common in women. Diagnosis is based on imaging (thoraco-abdominopelvic computed tomography scan +/- abdominal magnetic resonance) and histopathology. Clear cell carcinoma is the most frequently observed histological subtype. Management of localized kidney cancer involves surgery or ablative treatments. Active surveillance is indicated in the indolent oligometastatic setting with local treatment in case of localized progression. Apart from this specific situation, two first-line therapeutic strategies are recommended in the metastatic setting : a dual immunotherapy regimen or the combination of immunotherapy with an antiangiogenic tyrosine kinase inhibitor. Both combinations have demonstrated superior survival outcomes compared to sunitinib, the previous standard of care until 2019. Treatment selection should be individualized, considering the characteristics of the disease (histology, tumour burden, location of metastases and if they are threatening, speed of progression), potential side effects of the treatments, the patient's general health, comorbidities and preferences.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"323-329"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Towards optimal quality in anatomical pathology : standards, indicators and good practice]. [解剖学病理学的最佳质量:标准、指标和良好实践]。
Pub Date : 2025-05-01
Lionel Navez, Béatrice Akiki, Philippe Delvenne

The anatomical pathology laboratory receives human tissue samples, which are examined for the diagnosis of disease. At every stage of this process, from sending the sample to the laboratory to communicating the final diagnosis, there is a risk of error and nonconformity. This can affect the quality of the analyses that are performed. Standards and procedures exist, at the national and international levels. Applying these procedures and adhering to the current standards help to reduce risk of errors, to improve diagnostic accuracy and speed and ultimately to provide optimal patient care.

解剖病理实验室接收人体组织样本,对其进行检查以诊断疾病。在这个过程的每个阶段,从将样品送到实验室到传达最终诊断,都存在错误和不符合的风险。这可能会影响所执行分析的质量。在国家和国际两级都有标准和程序。应用这些程序并遵守现行标准有助于减少错误的风险,提高诊断的准确性和速度,并最终提供最佳的患者护理。
{"title":"[Towards optimal quality in anatomical pathology : standards, indicators and good practice].","authors":"Lionel Navez, Béatrice Akiki, Philippe Delvenne","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The anatomical pathology laboratory receives human tissue samples, which are examined for the diagnosis of disease. At every stage of this process, from sending the sample to the laboratory to communicating the final diagnosis, there is a risk of error and nonconformity. This can affect the quality of the analyses that are performed. Standards and procedures exist, at the national and international levels. Applying these procedures and adhering to the current standards help to reduce risk of errors, to improve diagnostic accuracy and speed and ultimately to provide optimal patient care.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"301-307"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hypertension : two European recommendations, two strategies, one clinical challenge]. [高血压:两个欧洲建议,两个策略,一个临床挑战]。
Pub Date : 2025-05-01
Justine Huart, François Jouret, Patrizio Lancellotti

After the joint publication of hypertension management guidelines in 2003, 2007, 2013, and 2018, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) decided to issue their recommendations separately - ESH in 2023 and ESC in 2024. Notable differences include the ESC's new blood pressure classification, which significantly impacts patient management. Other variations exist in diagnosis and treatment algorithms, yet both approaches remain complementary. Rather than a hurdle, this duality offers valuable flexibility, allowing treatment to be tailored to the patient and the clinician's judgment. The key priority remains: combating therapeutic inertia in this common condition with serious consequences.

在2003年、2007年、2013年和2018年联合发布高血压管理指南后,欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)决定分别发布他们的建议——ESH将于2023年发布,ESC将于2024年发布。值得注意的差异包括ESC的新血压分类,这对患者管理有显著影响。在诊断和治疗算法中存在其他变化,但两种方法仍然是互补的。而不是障碍,这种双重提供了宝贵的灵活性,允许治疗量身定制的病人和临床医生的判断。关键的优先事项仍然是:克服这种常见疾病的治疗惰性,造成严重后果。
{"title":"[Hypertension : two European recommendations, two strategies, one clinical challenge].","authors":"Justine Huart, François Jouret, Patrizio Lancellotti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>After the joint publication of hypertension management guidelines in 2003, 2007, 2013, and 2018, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) decided to issue their recommendations separately - ESH in 2023 and ESC in 2024. Notable differences include the ESC's new blood pressure classification, which significantly impacts patient management. Other variations exist in diagnosis and treatment algorithms, yet both approaches remain complementary. Rather than a hurdle, this duality offers valuable flexibility, allowing treatment to be tailored to the patient and the clinician's judgment. The key priority remains: combating therapeutic inertia in this common condition with serious consequences.</p>","PeriodicalId":94201,"journal":{"name":"Revue medicale de Liege","volume":"80 5-6","pages":"363-368"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144304170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revue medicale de Liege
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1